Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Purdue Pharma L.P. et al v. Teva Pharmaceuticals USA, Inc.
Case Number:
1:13-cv-04606
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 28, 2014
Judge Sends Abuse-Resistant OxyContin Patents To Trial
A New York federal judge on Tuesday issued a major claims construction ruling for two of Purdue Pharma LP's OxyContin patents that are designed to prevent abuse of the painkiller, clearing the way for a July bench trial with generic producers over whether the patents are valid.
-
July 03, 2013
Purdue Sues Teva To Block 'Abuse-Proof' OxyContin Generic
Purdue Pharma LP hit Teva Pharmaceuticals USA Inc. with a suit in federal court in New York on Tuesday accusing Teva of patent infringement for seeking approval for a generic "abuse-proof" version of the painkiller OxyContin.